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Introduction:
Kaposi's sarcoma (KS) represents an interestingmodel of
virally associated human neoplasms.**' The disease exhibits
multiple unique features in its histopatho1ogy and clinical
/ o \
course.^L} KS is amulti-focal, systemic neoplastic process,
which is histologically characterized by proliferating
fibroblastic andmicrovascular elements. However, it is unclear
whether this disorder is primarily amalignant neoplasm, or
whether it represents a reactive phenomenon. Some of the unusual
features of this neoplasm include: 1. Cluster distribution in
certain endemic areas, such as Zaire, Kenya, Tanzania, Eastern
Europe, Italy and North America;^3) 2. Male predominance with a
ratio of 10:15 males to one female in Africa and a 3:1
male:female ratio in the United States;^' 3. Diversity of
clinical presentations, from slow growing and indolent tumors,
predominating in European and North American populations to the
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fatal lymphadenopathic variant in African children;^ 4.
Occurrence of KS in renal transplant recipients, and patients
with iimunologic disorders following treatment with inrrmno-
suppressive agents;(4»5) 5. Serologic and genetic evidence for
close association between KS and cytomegalovirus 6»7 ; 6.
Increased incidence of second primary cancers in KS patients
especially lymphoreticular malignancies;*1' and 7. Marked
(8 9)
increase in the incidence of KS in the epidemic of AIDS.V »
Epidemiology^
The unusually high incidence of KS in the epidemic of AIDS
has lead the Center for DiseaseControl (CDC) to classifyKS as a
diagnostic presentation of AIDS in high-risk populations.^10^ KS
is reported as the initial manifestation of AIDS in approximately
30%of cases and this percentage has remained fairly constant
during the course of the epidemic.^1°'
At Memorial SIoan-Kettering Cancer Center, (MSKCC), we have
seenmore than 200 cases of KS since the beginning of the AIDS
epidemic. Themean age of of KS-AIDS at the time of their
initial diagnosis is 38years, with a range of 23-67 years. The
majority of KS-AIDS cases have been reported in men; however,
women with KS-AIDS have also been seen. In the MSKCC series,
there have thus far been only 2 female patients with KS-AIDS,
accounting for less than 1%of all cases. This is a skewed
population: largely because most KS-AIDS patients referred to
MSKCCare homosexual or bisexual men. It would be of great
interest to see whether KS-AIDS will show a similar prevalence
among men and women in certain geographic areas, such as Haiti or
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Africa, where AIDS is reported to be transmitted through
heterosexual contact. Preliminary data suggest that the number
of KS-AIDS cases among female intravenous drug abusers (IVDA) is
very close to those of male IVDA. KS-AIDS has been reported
among all risk groups for AIDS including children^11' and
hemophiliacs/12'. However, it is seen more frequently among
homosexual men. This is believed by some to be related to the
increased incidence of CMV infection in homosexual men. It is
also reported that KS-AIDS is seen more frequently among those
homosexuals who use unlabeled amyl nitrites rather than those who
use labeled ones'*^'. KS is more often seen among NewYork and
California AIDS cases than among those from other parts of the
country. In addition, it is more frequent among whites and
homosexuals than black and intravenous drug abusers.' j1^
The overall mortality rate of KS-AIDS is approximately 41%
(Figure 1), with over 60%of cases being alive by one year, and
50%by 22 months of follow-up. The overall survival of KS-AIDS
is said to be 18 months. However, there are cases who have
already lived 3-4 years and at present are still doing well.
Clinical presentation and course of the disease





presentations is one of the main features of KS-
Such diversity is seen in almost every feature of the
including the clinical presentations laboratory findings
biologic behavior of the tumor.
KS-AIDS is a multicentric neoplastic process which initially
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manifests with a single, or more frequently, multiple, pink, red
to violaceous macules, papules, and/or nodules on the skin or
mucosal surface.^17' The lesions then become darker and larger,
and may coalesce to form raised plaques, or tumors. The lesions
often appear elongated and oval in shape, and frequently follow
the linesofcleavageas seen inpityriasis rosea^ '. In rare
occasions, KS-AIDS lesions may manifest as small or large patches
of purple-blue discoloration, mimicking ecchymoses. KS-AIDS
lesions are frequently located on the trunk, upper extremities
and head and neck areas in contrast to the distribution of
lesions on the lower extremity in classical KS. The tip of the
nose is a common and unique location for KS-AIDS. Lesions on the
lower extremities are also seen in KS-AIDS but much less
frequently than those of classical KS. Soft tissue infiltrates
byKS tumor are also seen in the lower extremities. Involvement
of the soft tissues of the head and neck areas, however, is very
often seen, and carries with it a poor prognosis. Multiple sites
of involvement including mucous membranes, gasterointestina1 (GI)
tract and lymph nodes, are also characteristics of KS-AIDS. KS-
AIDSmay also initiallymanifest only with lesions in the mucous
membrane. The hard palate is one of the most common sites, but
tumors may infiltrate gingivae, oropharynx and tonsils.
Ulceration of the mucosal lesions is more common than in skin
lesions. Involvement of the upper and lower GI tract is seen in
approximately one third of the patients examined by endoscopy.
Early lesions in the GI tract may appear as pink to purple
submucosal macules of different sizes. Older lesions may
protrude into the muscosal surface and appear as nodules or
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tumors. Ulceration and bleeding from the GI tract lesions is
infrequently reported in KS-AIDS. Because of the deep location
of KS lesions in submucosal areas, biopsies of GI tract lesions
which are performed during gastroscopy are very often negative
for KS tumor. KS-AIDS has been frequently seen and reported in
the lymph node, and there have been cases in which KS-AIDS has
remained localized to the lymph node (personal observation). In
the MSKOC series, 47%of cases overall had lymph node disease.
Histologically, KS tumors are usually seen in the capsular area
of the lymph node; however replacement of the entire lymph node
has also been seen.
KS Lesions are also reported in the lung, 1iver,-pancreas,
adrenal gland, spleen and testis.<8>14> At postmortem, KS tumors
have been reported to involve almost all internal tissues, except
the brain. Patients with KS-AIDS also manifest-systemic
complaints of fever, weight loss, malaise, anorexia and
diarrhea(14'15).
The extent of KS tumors and their biologic behavior may vary
considerably. It maymanifest as slow-growing and indolent, or
rapid and fulminant. In general, the sites of KS-AIDS
involvement and the tumor load do not seem to correlate with the
prognosis of the disease. In addition, there is no correlation
between the initial site of KS tumor and the prognosis. We have
seen cases of KS-AIDSwith only very fewKS lesions in the late
stages of the disease. In contrast, there are cases withmassive
tumor involvement who have prolong survivals, and have responded
to treatment rapidly. An attempt has beenmade to develop a
staging classification for KS-AIDS.(19> However, staging of KS
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does not at this time seem to have prognostic or therapeutic
value. In another small number of the KS-AIDS cases who have
small tumor loads, the disease appears to be stable and not
progressive after several years of follow up.
Histopathology
Histopatholgic features of KS are characteristic and consist
of interweaving bands of spindle cells and vascular structures
embedded in a network of reticular and collagen fibers.*2^ The
vascular component appears mostly as cleft-like spaces or as
delicate capillaries. Spindle cellsmay showawide range of
nuclear pleomorphism in the tumor, and several different
histopathologic patterns may be identified. Histologic patterns
in KS tumormay vary from lesion to lesion and even in different
sections of the same lesion. In early lesions^19'20' dilated
vascular channels lined with normal-appearing endothelial cells
are present in the upper dermis. When the lining of the vascular
spaces lack erythrocytes, a lymphatic-channel-like appearance is
seen. Sparse mononuclear infiltrates composed mainly of
lymphocytes and plasma cells are observed. Siderophages are not
(20 21)
present inearly lesions. In the older lesions,v » ;
endothelial cells are more prominent, extravasated red cells and
siderophages are seen, and spindle cells with various degree of
pleomorphism and atypical it extend in various directions. It is
generally accepted that the histologic features of KS-AIDS are
indistinguishable from those of classical KS^20'21).
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Immunogenetic
Heritage and ethnicity appear to play a role in the
development of classical KS.<16) In North America themajority
of cases have ancestry going back to eastern Europe or Italy, or
are fromAshkenazi Jewish extraction^16K During the initial
phase of the epidemic of AIDS, there was an increased incidence
of KS-AIDS among (high-risk) individuals of Jewish or Italian
extraction, suggesting a possible role for ethnicity and heritage
as susceptibility factors. Later on, however, it became clear
that KS-AIDS can occur in persons from any ethnic group or
nationality.
Studies of major histocompatibi15ty complex antigens have
similarity demonstrated an increase in the frequency of
histocompatibi1ity leukocyte antigen (HLA)-DRS in classic
(22)
KSV '. An intial increase in the frequency ofHLA-DR5 amongKS-
AIDS cases with Italian and Jewish extraction and HLA-DR2 in
patients with Northern European extraction was observed. (22,23)
Present data, however, show that these antigens are no longer
seen with increased frequency, and therefore are not currently
considered risk factors for KS-AIDS. The reason for this change
in the frequency of the HLA class II antigen-association is not
as yet known, and requires further study. More recent data from
the MSKCC group (unpublished data) demonstrate that HLA-DRW53 is
significantly increased in all KS-AIDS populations except in
blacks. In addition, an increased frequency of HLA-DRW6 among
KS-AIDS-cases with Italian or other Caucasion background is
seen. Further studies are needed to clarify the possible role of
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HLA-associated susceptibility factors in KS-AIDS.
Laboratory Findings
These abnormal parameters appear to be closely associated
with the underlying infection of Human T Lymphotropic virus III
(HTLV-3)/Lymphadenopathy Associated Virus (LAV). In classical
KS, the major abnormal laboratory findings include: presence of
high levels of circulating anti-CMV antibodies^6'; anemia in a
very small percentage of cases' ' and a reduced ratio ofT
helper/T suppressor cells.'24) jn cases Of KS-AIDS, a
considerable number of laboratory parameters are found to be
abnormal. These factors may play amajor role in the prognosis,
response to therapy and the general outcome of the disease. In
the MSKCG series of KS-AIDS, a continuous decrease in the number
of white blood cells (WBC), absolute number? of neutrophils and
lymphocytes (Safai, et al, unpublished data) has been observed.
It has been shown that WBC and absolute lymphocyte counts are
closely associated with survival (p<.05). By two years from the
diagnosis 60%of the patients with normal WBCwere alive, as
compared to 45%of those with abnormal WBC. Similarly, patients
with normal absolute lymphocytes (55% alive by 2 years from
diagnosis) survived longer than patients with abnormal values
(30%alive by 2 years fromdiagnosis). The survival
distributions for these are shown in Figure 2 and 3.
Among the various laboratory parameters, the absolute number
of T helper cells and the ratio of T helper/T suppressor (T4/Tg)
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cells have special significance and have become the hallmark of
the disease. This Is a result of 1) the almost universal
finding in AIDS patients of a lowered number of T^ cells and
T^/Tg ratio; and 2) that the etiologic agent causing the
epidemic of AIDS, namely HTLV-3/LAV, has a special tropism for T
helper cells. In the cases seen at MSKCC, we have observed a
continuous and progressive decrease in the absolute number of T^
cells and T4/Tg ratio among themajority of cases. It was
observed that as the disease progressed, the number of T* cells
and the ratio of T^Tg continued to decrease to the end stage of
the disease. We have, however, found a small subgroup of KS-AIDS
cases who have normal values for these parameters in a 3-4 year
follow up period. These cases seem to have amore stable and
less aggressive disease. The observations indicate the presence
of a spectrumof disease presentations inKS-AIDS.^ ' In
addition, the data suggest that the abnormal number of T4 cells
or the T^/Tg ratio is not a pre-requisite for the development of
KS. Thus, the level of immune deficiency needed for this tumor
to arise is perhaps not measurable by the presently available
laboratory assays. In the cases of classical KS we have also
observed a reduction in the ratio of T^/Tg^2^'. However, these
lowered values are stable and not progressively decreasing which
is amajor difference from those of KS-AIDS.
In testing for an association between these variables and an
increase in survival both were found to be significant
(P ^.05). Figures 4 and 5 contains the survival distributions
for these variables. Patients with 30%or more T^ cells survived
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longer（68％81lYe by　2　ye且rs，rom di叩nOs王8）than cases with
fewer than30％T4Cells（44％且IIYe by2ye8r6　from di叩nOSi6）．
Similarly，patients with T4／T8　r且tiosless thanl・O h8d　8lower
占urViv且Ir且te than p8tients who h且d邑T4／Ts r且tio betweenl・O and
l・6，Or th8n those who had a T4／T8　0f atleastl．7・The
PrOPOrtion alive at　2　ye且rS from diagnosis was　43％，64％and　93％
respectively for these three groups・When comp色ring the number
Of T4Cells and the T4／T8　ratioin patients with KS－AIDS to high
risk controIsIitis cle且r that thereis a statistically
Signficant difference（P＜・05）・The patients had a muchlower T4
Cells and T4／T8　r且tio than the controIs・
Functionalstudies of T cells and B cellsin patients with
KS．AIDS have indicated　且　Close　8SSOCi且tion between these
PaTa－meterS　且nd the course and prognosis of the disease－　Detailed
information has been reported previouslyin this regard（26）ln
Our Series of KS－AIDS c且SeS We h8Ve demonstr8ted a general
decreasein the functionalcap8Cities of the T and B cellsin the
m8jority of the c邑SeS．　The prolifer且tiYe reSPOnSe tO E．coliand
Con－A　且PpearS tO be a more sensitiveindic8tOrin this group of
Patientsi By　2　years from di8gnOSis，80％of the patients with
normalCon－A responsiveness were Stillalive，COmPared with only
38％of p且tients with abnormalCon－A responses surviving・
Patients with higherlevels of E・COliresponsiveness survived
longer than patients withloweredlevels・　Similarly the response
to CMV　且ntigens was closely correlated with survivalof KS－AIDS
patients（Figures　6，7，8）i However，且　Smallsubgroup of KS－
AIDS p且tients have normalprolifer且tiYe reSPOnSiveness to various
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T and B cell mitogens. These observations again support the
concept thatmeasurable loss of Tand Bcell functions is not a
prerequisite for the development of KS in AIDS victims. Perhaps
more subtle alterations in inmune competence or a specific loss
of immunologic function, is needed to allow the tumor to grow.
Following the discovery of the etiologic agent of the
epidemic of AIDS, it has been shown that cases of classical KS
are negative for the HTLV-3/LAV (Safai, et al unpublished
data). However, nearly all cases of KS-AIDS who have been so far
tested have shown antibodies to the HTLV-3/LAV, and the virus has
been isolated frommost of the cases cultured.^*'"") This
information clearly suggests that HTLV-3/LAV is not the etiologic
agent of KS but may account for its different biologic behavior
in AIDS. In the MSKCC series of KS-AIDS, antibodies to HTLV-
3/LAV have been observed. It is of interest to note that the
levels of HTLV-3/LAV antibodies decrease as the disease
progresses.'"^ However, this appears to be unrelated to the
progress of the KS tumor. In addition, we have learned that
those individuals who have higher levels of antibodies to HTLV-
3/LAV, have a better prognosis, both for their KS tumor and for
their AIDS (opportunistic infections). In a small subgroup of KS
patients we have been unable to demonstrate the presence of HTLV-
3/LAV antibodies (Safai, et al unpublished data). These
individuals are mostly young men of high risk groups
(homosexuals) who have shown either stable KS tumor or have
responded well to treatment (interferon). Whether these
individuals are suffering from KS-AIDS, or whether they have
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developed ft classical form of the disease is unclear. Attempts
to isolate HTLV-3/LAV from these cases are underway.
Pathogenesis
While KS has been diagnosed in approximately 30%of AIDS
victims, the association of this tumor and the HTLV-3/LAV
infection is not well understood. It is speculated that irrmune
deficiencymight play a role in the development of KS. However,
in the MSKCC series we have observed cases of KS-AIDS in whom
measurable Immune deficiency or abnormalities of the immune
regulation can not be identified. Therefore, it is possible that
the inmune deficiency which is prerequisite for KS to develop 5s
either segmented and/or not measurable to the available tests.
In addition, themajority of AIDS victims (70%) do not develop
KS, while they still have severe immune deficiency. Thus it is
likely that other factors might be involved in the development of
this tumor. In fact, KS is mostly seen in homosexual men,
indicating a possible involvement of the life style factors
closely associated with homosexuality. For example, a recent
investigation reports that homosexuals using unlabeled nitrite
inhalants are at higher risk for developing KS than those who use
/1o\
this drug in a labeled form.v '
In addition to the possible role of immune deficiency, CMV
infection and genetic host factors have been speculated to be
involved in development of KS. In general, it appears that
multiple factors are needed for the KS tumor to develop, and the
multiplicity of the presentations of this tumor depends on the
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levels at which these factors are Influencing tumorogenesis. The
final outcome of the disease process appears to be under the
influence of all these factors.
An interesting but unanswered question concerns the
association of HTLV-3/LAV infection and development of KS,
especially when this agent is not the etiologic agent of this
tumor in the classical form of KS. Two different hypothesis
could be offered: 1) Infection with HTLV-3/LAV acts as the
promotor factor for the development of KS, i.e. infected
mononuclear cells produce angiogenic factors, which in turn allow
the development and proliferation of the involved KS cell, in the
presence of other required factors. 2. In the high risk
populations for AIDS, the necessary factors for development of KS
are present and infection with HTLV-3/LAV provides the final
factor, whether a segmental immune deficiency state or the
promotor factor. Much work is needed to provide answers for some
of these intriguing questions.
22
0 ALL KS-AJDS PATIENTS (202 PTS. ||9 CENSORED)































Fig. 1. Survival for all patients with KS-AIDS.
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Fig. 2. Survival distributions by initial white blood cell count-normal levels vs abnormal levels.
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Fig. 3. Survival distributions by absolute lymphocyte count-normal vs abnormal levels.
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Fig. 4. Survival distributions by percentage initial T4 cells-at least 30% vs less than 30%.
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Fig. 5. Survival distributions by initial T4/T8 ratio-less than 1.0 vs between 1.0 and 1.6 vs at least 1.7.
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Fig. 6. Survival distributions by initial conconavalin A-normal levels vs abnormal levels.
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Fig. 7. Survival distributions by initial E. coli-less than 101 vs between 101 and 1050 vs greater than 1050.
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